Correlation Between Oncorus and Zura Bio
Can any of the company-specific risk be diversified away by investing in both Oncorus and Zura Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncorus and Zura Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncorus and Zura Bio Limited, you can compare the effects of market volatilities on Oncorus and Zura Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncorus with a short position of Zura Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncorus and Zura Bio.
Diversification Opportunities for Oncorus and Zura Bio
Pay attention - limited upside
The 3 months correlation between Oncorus and Zura is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Oncorus and Zura Bio Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zura Bio Limited and Oncorus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncorus are associated (or correlated) with Zura Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zura Bio Limited has no effect on the direction of Oncorus i.e., Oncorus and Zura Bio go up and down completely randomly.
Pair Corralation between Oncorus and Zura Bio
If you would invest (100.00) in Oncorus on December 11, 2024 and sell it today you would earn a total of 100.00 from holding Oncorus or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Oncorus vs. Zura Bio Limited
Performance |
Timeline |
Oncorus |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Zura Bio Limited |
Oncorus and Zura Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oncorus and Zura Bio
The main advantage of trading using opposite Oncorus and Zura Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncorus position performs unexpectedly, Zura Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zura Bio will offset losses from the drop in Zura Bio's long position.Oncorus vs. Apollomics Class A | ||
Oncorus vs. Pyxis Oncology | ||
Oncorus vs. Zura Bio Limited | ||
Oncorus vs. Elevation Oncology |
Zura Bio vs. ServiceNow | ||
Zura Bio vs. Ark Restaurants Corp | ||
Zura Bio vs. Uber Technologies | ||
Zura Bio vs. Alvotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |